Company / Income Tax per Share
Aclaris Therapeutics, Inc. Income Tax per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.01
FY2024
5-year range
-$0.01 / -$0.01
FY2020-FY2024
Trend
+5.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.00 to $-0.01 over the past 4 years.
Based on SEC 10-K filings.
-0.01 in FY2024.
Improved from $-0.00 to $-0.01 over the past 4 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, income tax per share increased 5.9% year-over-year.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$0.01 | +5.9% |
| FY2023 | -$0.01 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$0.00 | +90.1% |
| FY2019 | -$0.04 | - |
| FY2018 | - | - |
| FY2017 | -$0.07 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026